期刊文献+

Caspases在TRAIL诱导MG-63骨肉瘤细胞株凋亡中的作用 被引量:1

Role of Caspases during TNF-related Apoptosis-inducingLigand Killing Osteosrarcoma Cell Lines
下载PDF
导出
摘要 目的 :初步观察并探讨人重组可溶性肿瘤坏死因子相关凋亡诱导配体 (TNF relatedapoptosis inducinglig and ,TRAIL)蛋白诱导MG 6 3骨肉瘤细胞凋亡的作用机制。方法 :用RT PCR检测TRAIL受体在MG 6 3骨肉瘤细胞上的表达 ;用MTT试验检测TRAIL对MG 6 3细胞的抑制率及加入Caspase抑制剂后TRAIL对MG 6 3骨肉瘤细胞株抑制率的变化。初步分析TRAIL诱导MG 6 3骨肉瘤细胞株凋亡的作用机理。结果 :当TRAIL单独作用于MG 6 3骨肉瘤细胞株时 ,可产生明显的抑制效果 ;而当TRAIL分别加入广谱的Caspase抑制剂zVAD FMK、Caspase 8的抑制剂zIETD FMK、Caspase 3的抑制剂zDEVD FMK与细胞株MG 6 3共同孵育时 ,TRAIL的抑制作用均被阻断。结论 :TRAIL可能是通过与细胞膜表面的死亡受体结合 ,然后激发细胞内Caspase级联反应从而诱导肿瘤细胞凋亡的。 Objective: To investigate molecular mechanism of TNF-related apoptosis-inducing ligand(TRAIL)-induced apoptosis in MG-63 osteosarcoma cell line. Methods: To assess rTRAIL-mediated cytotoxicity in MG-63 osteosarcoma cell line, MG-63 cells were treated for 24 hours with different concentration of sTRAIL and cell death was evaluated with the MTT assay.To evaluate effect of Caspase inhibitors, MG-63 cell line was treated with sTRAIL and zVAD-FMK, zIETD-FMK or zDEVD-FMK respectively. The expression of TRAIL receptors in MG-63 osteosarcoma cell line was studied with RT-PCR. Results: MG-63 osteosarcoma cell line was sensitive to sTRAIL, but it was resistant to apoptosis when treated with sTRAIL and Caspase inhibitors. Conclusion: TRAIL could establish a complex with death receptors and activate Caspase casade, which induced apoptosis in MG-63 osteosarcoma cell line.
出处 《武汉大学学报(医学版)》 CAS 2004年第5期497-500,共4页 Medical Journal of Wuhan University
基金 湖北省自然科学基金资助项目 (项目编号 :3 0 113 0 72 0 )
关键词 肿瘤坏死因子相关凋亡诱导配体 骨肉瘤 凋亡 CASPASES TRAIL osteosarcoma apoptosis Caspases
  • 相关文献

参考文献11

  • 1Pitti RM, Masters SA, Ruppert S, et al. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem, 1996, 271:12 678
  • 2Nicholas M, Vassiliki P, Constantine M, et al. Ewing's Sarcoma Family Tumors Are Sensitive to Tumor Necrosis Factor-related Apoptosis-inducing Ligand and Express Death Receptor 4 and Death Receptor 5. Cancer Res,2001, 61:2 704
  • 3Pan G, O' Rourke K, Chinnaiyan AM, et al. The receptor for the cytotoxic ligand TRAIL. Science, 1997, 276:111
  • 4Degli-Esposti MA, Dougall WC, Smolak PJ, et al. The novel receptor TRAIL-R4 induces NFk-B and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. Immunity, 1997, 7:813
  • 5Emery JG, McDonnell P, Burke MB, et al. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Bio Chem, 1998, 273:14 363
  • 6Zhang XD, Franco A, Myers K, et al. Relation of TNFrelated apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma. Cancer Res, 1999, 59:2 747
  • 7Frank S, Kohler U, Schackert HK. Expression of TRAIL and its receptors in human brain tumors. Biochem Biophys Res Commun, 1999, 257:454
  • 8Sheridan JP, Masters SA, Pitti RM, et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science, 277:818
  • 9Griffith TS, Chin WA, Jaackson GC, et al. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J Immunol, 1998, 161:2 833
  • 10Jeremias I, Herr I, Bochler T, et al. TRAIL/Apo-2-ligand-induced apoptosis in human T cells. Eur J Immunol,1998, 28:143

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部